Original-Research: EasyMotionSkin Tec AG (von GBC AG):
Original-Research: EasyMotionSkin Tec AG - von GBC AG
Einstufung von GBC AG zu EasyMotionSkin Tec AG
Unternehmen: EasyMotionSkin Tec AG
ISIN: LI1147158318
Anlass der Studie: Research Comment
Letzte Ratingänderung:
Analyst: Matthias Greiffenberger, Marcel Schaffer
EasyMotionSkin Tec AG is expanding its portfolio with the acquisition of
milongroup, a strategic move that solidifies the company's position in the
healthcare sector. As part of this development, mid-term forecast
adjustments are currently underway.
At an extraordinary general meeting, EasyMotionSkin Tec AG greenlit the
acquisition of milongroup, marking a significant expansion of the company's
offerings in the realm of healthcare solutions. To facilitate this growth,
the company increased its share capital from 1.00 million CHF to 2.92
million CHF. This was achieved through the issuance of 19.20 million new
registered shares, each with a nominal value of 0.10 CHF per share and an
issue price of 5.8325 CHF per share, against a contribution in kind. An
expert report assessed the company value of Milongroup at 111.98 million
CHF. Milongroup, operating in the fitness and healthcare sector, achieved a
revenue of 29.44 million euros in the last fiscal year, with a net profit
of 1.02 million euros. Milongroup is known for its high-quality, highly
digitized fitness equipment in the B2B segment. The integration of
milongroup presents significant growth opportunities through cross-selling,
expanding into new customer segments, internationalization, and
digitization. This strategic move transforms EasyMotionSkin into a holistic
healthcare provider, serving both the B2B and B2C segments and expanding
its product offerings.
Milongroup stands as a leading provider in the professional training
sector, bringing together the brands milon and five. The company offers
comprehensive training solutions to studios and healthcare facilities
worldwide, characterized by innovative equipment and modern methodologies.
The training philosophy is grounded in contemporary sports science and
physiotherapeutic knowledge, delivering an ideal blend of strength and
flexibility training suitable for people of all ages and fitness goals.
This approach enables personalized and effective training for operators,
trainers, and trainees. Furthermore, their electronically controlled
Q-devices are registered as active medical devices and adhere to the
European Medical Device Regulation (MDR), making them suitable for use in
hospitals and clinics.
The strategic move's objective is to establish a comprehensive health
technology conglomerate dedicated to enhancing well-being in various
domains, including physical fitness, agility, health, and the potential
extension of individuals' lifespans.
The acquisition has brought significant changes to the company's outlook
and scale. We anticipate releasing a new mid-term forecast in the near
future.
Die vollständige Analyse können Sie hier downloaden: http://www.more-ir.de/d/27889.pdf
Kontakt für Rückfragen
GBC AG
Halderstraße 27
86150 Augsburg
0821 / 241133 0
research@gbc-ag.de
++++++++++++++++
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,7,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter:
http://www.gbc-ag.de/de/Offenlegung
+++++++++++++++
Date (time) of completion: 18.10.2023 (19:10)
Date (time) of first distribution: 19.10.2023 (11:00)
-------------------übermittelt durch die EQS Group AG.-------------------
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
| Sales1 | 1,48 | 1,75 | 3,79 | 2,43 | 6,00 | 3,83 | 32,00 | |
| EBITDA1,2 | -0,01 | -0,16 | -2,95 | -0,20 | 0,96 | -1,54 | -4,00 | |
| EBITDA-Margin3 | -0,68 | -9,14 | -77,84 | -8,23 | 16,00 | -40,21 | -12,50 | |
| EBIT1,4 | -0,14 | -0,24 | -2,95 | -0,34 | 0,96 | -1,54 | 0,00 | |
| EBIT-Margin5 | -9,46 | -13,71 | -77,84 | -13,99 | 16,00 | -40,21 | 0,00 | |
| Net Profit (Loss)1 | -0,84 | -0,26 | 3,95 | -0,38 | 0,71 | -1,74 | 0,00 | |
| Net-Margin6 | -56,76 | -14,86 | 104,22 | -15,64 | 11,83 | -45,43 | 0,00 | |
| Cashflow1,7 | -0,84 | -0,26 | 3,95 | -0,25 | 0,71 | -1,74 | 0,00 | |
| Earnings per share8 | -0,08 | -0,03 | 0,39 | -0,04 | 0,07 | -0,06 | -0,09 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Grant Thornton
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| EasyMotion Tec | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A3C7M8 | LI1147158318 | AG | 137,24 Mio € | 09.12.2021 | 8FVF4GC9+2H | |
| PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 0,00 | 0,00 | 0,00 | -156,67 | 1,08 | -79,06 | 4,29 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 26.08.2024 | 29.03.2024 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +0,26% | +16,83% | -14,55% | -29,32% | -67,59% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
